Literature DB >> 35187887

A high-efficiency and versatile CRISPR/Cas9-mediated HDR-based biallelic editing system.

Xinyi Li1,2, Bing Sun1, Hongrun Qian1, Jinrong Ma1, Magdalena Paolino2, Zhiying Zhang3.   

Abstract

Clustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 nuclease (Cas9), the third-generation genome editing tool, has been favored because of its high efficiency and clear system composition. In this technology, the introduced double-strand breaks (DSBs) are mainly repaired by non-homologous end joining (NHEJ) or homology-directed repair (HDR) pathways. The high-fidelity HDR pathway is used for genome modification, which can introduce artificially controllable insertions, deletions, or substitutions carried by the donor templates. Although high-level knock-out can be easily achieved by NHEJ, accurate HDR-mediated knock-in remains a technical challenge. In most circumstances, although both alleles are broken by endonucleases, only one can be repaired by HDR, and the other one is usually recombined by NHEJ. For gene function studies or disease model establishment, biallelic editing to generate homozygous cell lines and homozygotes is needed to ensure consistent phenotypes. Thus, there is an urgent need for an efficient biallelic editing system. Here, we developed three pairs of integrated selection systems, where each of the two selection cassettes contained one drug-screening gene and one fluorescent marker. Flanked by homologous arms containing the mutated sequences, the selection cassettes were integrated into the target site, mediated by CRISPR/Cas9-induced HDR. Positively targeted cell clones were massively enriched by fluorescent microscopy after screening for drug resistance. We tested this novel method on the amyloid precursor protein (APP) and presenilin 1 (PSEN1) loci and demonstrated up to 82.0% biallelic editing efficiency after optimization. Our results indicate that this strategy can provide a new efficient approach for biallelic editing and lay a foundation for establishment of an easier and more efficient disease model.

Entities:  

Keywords:  Biallelic editing; CRISPR/Cas9; Homology-directed repair (HDR); Homozygote

Mesh:

Year:  2022        PMID: 35187887      PMCID: PMC8861562          DOI: 10.1631/jzus.B2100196

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  34 in total

1.  Dual-reporter surrogate systems for efficient enrichment of genetically modified cells.

Authors:  Chonghua Ren; Kun Xu; Zhongtian Liu; Juncen Shen; Furong Han; Zhilong Chen; Zhiying Zhang
Journal:  Cell Mol Life Sci       Date:  2015-03-01       Impact factor: 9.261

Review 2.  Cell cycle-dependent control of homologous recombination.

Authors:  Xin Zhao; Chengwen Wei; Jingjing Li; Poyuan Xing; Jingyao Li; Sihao Zheng; Xuefeng Chen
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2017-08-01       Impact factor: 3.848

3.  Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.

Authors:  Lin Ye; Jiaming Wang; Yuting Tan; Ashley I Beyer; Fei Xie; Marcus O Muench; Yuet Wai Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

4.  Enhanced CRISPR/Cas9-mediated biallelic genome targeting with dual surrogate reporter-integrated donors.

Authors:  Yun Wu; Kun Xu; Chonghua Ren; Xinyi Li; Huijiao Lv; Furong Han; Zehui Wei; Xin Wang; Zhiying Zhang
Journal:  FEBS Lett       Date:  2017-03-08       Impact factor: 4.124

Review 5.  Is non-homologous end-joining really an inherently error-prone process?

Authors:  Mireille Bétermier; Pascale Bertrand; Bernard S Lopez
Journal:  PLoS Genet       Date:  2014-01-16       Impact factor: 5.917

6.  Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase.

Authors:  Reto Eggenschwiler; Mohsen Moslem; Mariane Serra Fráguas; Melanie Galla; Oliver Papp; Maximilian Naujock; Ines Fonfara; Ingrid Gensch; Annabell Wähner; Abbas Beh-Pajooh; Claudio Mussolino; Marcel Tauscher; Doris Steinemann; Florian Wegner; Susanne Petri; Axel Schambach; Emmanuelle Charpentier; Toni Cathomen; Tobias Cantz
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

7.  Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair.

Authors:  Natasa Savic; Femke Cas Ringnalda; Helen Lindsay; Christian Berk; Katja Bargsten; Yizhou Li; Dario Neri; Mark D Robinson; Constance Ciaudo; Jonathan Hall; Martin Jinek; Gerald Schwank
Journal:  Elife       Date:  2018-05-29       Impact factor: 8.140

8.  CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.

Authors:  Chao Li; Eleanor Brant; Hikmet Budak; Baohong Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2021-04-15       Impact factor: 3.066

9.  A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression.

Authors:  Linghe Xi; Jens C Schmidt; Arthur J Zaug; Dante R Ascarrunz; Thomas R Cech
Journal:  Genome Biol       Date:  2015-11-10       Impact factor: 13.583

10.  Search-and-replace genome editing without double-strand breaks or donor DNA.

Authors:  Andrew V Anzalone; Peyton B Randolph; Jessie R Davis; Alexander A Sousa; Luke W Koblan; Jonathan M Levy; Peter J Chen; Christopher Wilson; Gregory A Newby; Aditya Raguram; David R Liu
Journal:  Nature       Date:  2019-10-21       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.